A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma.
Elaine ChangJiaxi ZhouChi SongHaley GittlemanLaura L FernandesChana WeinstockMichael B AtkinsSundeep AgrawalRajeshwari SridharaNicole J GormleyShenghui TangDaniel L SuzmanLaleh Amiri-KordestaniPaul G KluetzRichard PazdurBrian I RiniDavid F McDermottMeredith M ReganPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
In this post hoc partitioned survival analysis, TFS and TFS without toxicity appeared similar in the IO-TKI group compared to the SUN group. These findings may reflect continuation of TKI until progression per protocol design in all trials and discontinuation of IO after 2 years in 2 trials.